These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37927102)

  • 1. Unresolved issues with noninferiority pragmatic trials: Results of a literature survey.
    Ciarleglio MM; Li J; Peduzzi P
    Clin Trials; 2024 Apr; 21(2):242-256. PubMed ID: 37927102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol adherence rates in superiority and noninferiority randomized clinical trials published in high impact medical journals.
    Bamat NA; Ekhaguere OA; Zhang L; Flannery DD; Handley SC; Herrick HM; Ellenberg SS
    Clin Trials; 2020 Oct; 17(5):552-559. PubMed ID: 32666826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninferiority Designed Cardiovascular Trials in Highest-Impact Journals.
    Bikdeli B; Welsh JW; Akram Y; Punnanithinont N; Lee I; Desai NR; Kaul S; Stone GW; Ross JS; Krumholz HM
    Circulation; 2019 Jul; 140(5):379-389. PubMed ID: 31177811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-inferiority trials: are they inferior? A systematic review of reporting in major medical journals.
    Rehal S; Morris TP; Fielding K; Carpenter JR; Phillips PP
    BMJ Open; 2016 Oct; 6(10):e012594. PubMed ID: 27855102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of reporting of noninferiority and equivalence randomized trials.
    Le Henanff A; Giraudeau B; Baron G; Ravaud P
    JAMA; 2006 Mar; 295(10):1147-51. PubMed ID: 16522835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of noninferiority margins reported in protocols and publications showed incomplete and inconsistent reporting.
    Dekkers OM; Cevallos M; Bührer J; Poncet A; Ackermann Rau S; Perneger TV; Egger M
    J Clin Epidemiol; 2015 May; 68(5):510-7. PubMed ID: 25450451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical issues and recommendations for noninferiority trials in oncology: a systematic review.
    Tanaka S; Kinjo Y; Kataoka Y; Yoshimura K; Teramukai S
    Clin Cancer Res; 2012 Apr; 18(7):1837-47. PubMed ID: 22317762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients and investigators prefer measures of absolute risk in subgroups for pragmatic randomized trials.
    Murray EJ; Caniglia EC; Swanson SA; Hernández-Díaz S; Hernán MA
    J Clin Epidemiol; 2018 Nov; 103():10-21. PubMed ID: 29966732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cluster over individual randomization: are study design choices appropriately justified? Review of a random sample of trials.
    Taljaard M; Goldstein CE; Giraudeau B; Nicholls SG; Carroll K; Hey SP; Brehaut JC; Jairath V; London AJ; Eldridge SM; Grimshaw JM; Fergusson DA; Weijer C
    Clin Trials; 2020 Jun; 17(3):253-263. PubMed ID: 32367741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Person-centred experiential therapy versus cognitive behavioural therapy delivered in the English Improving Access to Psychological Therapies service for the treatment of moderate or severe depression (PRaCTICED): a pragmatic, randomised, non-inferiority trial.
    Barkham M; Saxon D; Hardy GE; Bradburn M; Galloway D; Wickramasekera N; Keetharuth AD; Bower P; King M; Elliott R; Gabriel L; Kellett S; Shaw S; Wilkinson T; Connell J; Harrison P; Ardern K; Bishop-Edwards L; Ashley K; Ohlsen S; Pilling S; Waller G; Brazier JE
    Lancet Psychiatry; 2021 Jun; 8(6):487-499. PubMed ID: 34000240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the Justification, Funding, Success, and Survival Outcomes of Randomized Noninferiority Trials of Cancer Drugs: A Systematic Review and Pooled Analysis.
    Gyawali B; Tessema FA; Jung EH; Kesselheim AS
    JAMA Netw Open; 2019 Aug; 2(8):e199570. PubMed ID: 31469391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled trials and neurosurgery: the ideal fit or should alternative methodologies be considered?
    Mansouri A; Cooper B; Shin SM; Kondziolka D
    J Neurosurg; 2016 Feb; 124(2):558-68. PubMed ID: 26315006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonadherence to treatment protocol in published randomised controlled trials: a review.
    Dodd S; White IR; Williamson P
    Trials; 2012 Jun; 13():84. PubMed ID: 22709676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond the intention-to-treat in comparative effectiveness research.
    Hernán MA; Hernández-Díaz S
    Clin Trials; 2012 Feb; 9(1):48-55. PubMed ID: 21948059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial discs for lumbar and cervical degenerative disc disease -update: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(10):1-98. PubMed ID: 23074480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Airway clearance devices for cystic fibrosis: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(26):1-50. PubMed ID: 23074531
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.